FDA Announces 1/18 Meeting to Discuss Philip Morris MRTP Applications
FDA has published a notice announcing a meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) for Jan. 24-25, 2018, at the FDA White Oak campus. The committee will discuss scientific issues related to the modified risk tobacco product (MRTP) applications submitted by Philip Morris Products S.A. for its iQOS system and several Marlboro HeatSticks products, which are currently under scientific review by FDA.
Requests must be submitted to present an oral comment at the TPSAC meeting byDec. 27, 2017. If you cannot attend the meeting, you may still submit a written comment to the FDA by Jan. 4, 2018. For more information, please see the Federal Register notice.
Latest posts by Gregory Brown (see all)
- Why Forming a Pass-Through Entity Can Make Sense For your Business - January 23, 2018
- What Happens if a Fiduciary Duty is Breached? - January 20, 2018
- What are the Pros and Cons of Settling a Case - January 16, 2018